View
31
Download
0
Category
Preview:
DESCRIPTION
High Blood Pressure Increases Mortality Among HIV Seropositive Individuals Without AIDS in Western Kenya. Gerald S. Bloomfield 1 , Joseph W. Hogan 2 , Alfred Keter 3 , Thomas L. Holland 1 , James Osanya 3 , Edwin Sang 3 , Sylvester Kimaiyo 3 , Eric J. Velazquez 1 - PowerPoint PPT Presentation
Citation preview
High Blood Pressure Increases Mortality Among HIV Seropositive Individuals
Without AIDS in Western KenyaGerald S. Bloomfield1, Joseph W. Hogan2, Alfred Keter3, Thomas L. Holland1,
James Osanya3, Edwin Sang3, Sylvester Kimaiyo3, Eric J. Velazquez1
1Duke University, Durham, NC, USA; 2Brown University, Providence, RI, USA;
3Moi University School of Medicine, Eldoret, Kenya
AHA Scientific Sessions 2012
Abstract # 10909
Financial Disclosures
• None
Background
• HIV is associated with cardiovascular (CV) disease
• Most (>60%) HIV+ patients reside in Africa but CV risk in this population is not well-studied
• Call for integration of communicable / non-communicable disease care in low- and middle-income countries
-United Nations High Level Meeting 2011
Rationale
• Despite importance of CV disease globally and large HIV burden in Africa, no studies examining CV disease and mortality in HIV in the region
• Among Kenyan HIV+ patients without AIDS:– High blood pressure is associated with higher risk
of death– The blood pressure-mortality relationship varies
with World Health Organization HIV clinical stage
Hypotheses
Methodology
• Retrospective analysis of clinically-obtained patient medical records
• Large HIV treatment program in Kenya– Academic Model Providing Access to
Healthcare (AMPATH) – >115,000 adults enrolled from >20 clinics– Blood pressure from electronic medical
record
Study Site
Methodology
• Included data for 2005-10, ≥16 years old• Excluded those with AIDS, missing blood
pressure,CD4 count or pregnant• Categorized age, CD4, and blood pressure
– Systolic BP: <100, 100-119, 120-139, ≥140
• Calculated:– Unadjusted mortality incidence rate– Risk of death with proportional hazards
regression models
Results
• 30,231 patients • Median age 33.5 years (28-41), 75% female,
CD4 396 (287-556), 60% on HIV therapy• Incidence rate (IR) of death higher if SBP ≥140
SBPin mmHg
Person years(pyrs)
Deaths IR per 100 pyrs (95% CI)
<100 6190 207 3.3 (2.9-3.8)
100-119 39342 698 1.8 (1.6-1.9)
120-139 20323 285 1.4 (1.2-1.6)
≥140 2866 62 2.2 (1.7-2.8)
Overall 68721 1252 1.8 (1.7-1.9)
Proportional Hazard of Death
Other covariates: age, diastolic BP, creatinine, body mass index, hemoglobin, anti-retroviral therapy, residence, marital status, sex in combined analysis
Variable Women (n=16489)
Men (n=5507)
Combined (n=22356)
Systolic BP in mmHg
<100 1.2 (1.0 - 1.6) 1.3 (0.9 - 1.9) 1.3 (1.0 - 1.5)
100-119 ref ref ref
120-139 0.9 (0.7 - 1.1) 0.8 (0.6 - 1.1) 0.9 (0.7 - 1.0)
≥140 1.5 (1.0 - 2.3) 2.0 (1. 3- 3.1) 1.8 (1.3 - 2.4)
WHO HIV Stage
1 ref ref ref
2 1.5 (1.2 – 1.8) 1.4 (1.1 – 1.8) 1.4 (1.2 – 1.7)
3 2.3 (1.9 – 2.9) 2.0 (1.5 – 2.7) 2.2 (1.8 – 2.6)
CD4 <350 2.1 (1.8 – 2.6) 1.6 (1.3 – 2.1) 1.9 (1.7 – 2.3)
Mortality Rate Stratified by SBP & WHO Stage
Mortality0.24
0.12
0.0
Systolic BP --- <100 --- 100-119 --- 120-139 --- ≥140Time in Years
0.08
0.18
0.10
0.04
SBP, Stage 1 SBP, Stage 2 SBP, Stage 3
0 4 8
Conclusions
• High blood pressure is associated with high death rate in HIV+ Kenyans without AIDS
• The effect of high blood pressure on mortality is comparable to that of HIV immune status
• Greater effect of SBP on mortality with worse clinical stage of HIV
• Limitations: Observational study, clinically-obtained data
Implications
• Blood pressure control is a missed opportunity to modify health in HIV+
• There is need for expansion of HIV programs to address CV diseases (IOM report 2010)
Recommended